Furthermore, the proposed results on JAK/STAT signaling involvement in tendinopathy are not conclusive and require further in vitro studies, also using well-known JAK inhibitors or agonists, to confirm the putative role of this pathway in normal and pathological conditions. This evidence concerns the gene SOAT1 and disease of the tendon.